Skip to main content
. 2005 Dec;187(23):7881–7889. doi: 10.1128/JB.187.23.7881-7889.2005

TABLE 1.

Oligonucleotides used in this studya

Experiment Oligonucleotide Nucleotide sequence
rpa3 cloning MacRPA3F 5′ CATATGGATGAGAAAATTGCGCCCCAACTTG
MacRPA3R 5′ CTCGAGTTAAGCAAGGTTAATTCCTCCTTCG
Mutagenesis C313A-F 5′ CGGGAATAATTACCCGCGCCCCCGAATGCAGCCGCGTG
C313A-R 5′ CACGCGGCTGCATTCGGGGGCGCGGGTAATTATTCCCG
C316A 5′ ATTACCCGCTGCCCCGAAGCCAGCCGCGTGGTCCAG
C325A 5′ GTCCAGAAAGGAAACGCCAGGGTGCACGGCAAGGTG
H328A 5′ GGAAACTGCAGGGTGGCCGGCAAGGTGGAAGGC
Gene truncation RPA3F2 5′ CATATGGCAGCAAAAGAACCTGCCCTCCTG
RPA3R2 5′ CTCGAGTCAGCCTGCAGTAGCTACGTCAAACATG
EMSA MacMC-R 5′ TTTTCTCGAGTTATGCCACGAGTTTTACATGCTCCTTGCCCC
Primer extension M13 6205-6234 5′ ATTCGTAATCATGGTCATAGCTGTTTCCTG
a

The experiments in which the oligonucleotides were used are indicated. The rpa3 oligonucleotides were used to clone MacRPA3. The mutagenesis oligonucleotides were used to create site-directed mutations in the putative zinc finger motif in MacRPA3. The gene truncation oligonucleotides were combined with the oligonucleotides used in cloning MacRPA3 to create truncated proteins with or without the coding sequences for the putative zinc finger motif. The EMSA and primer extension oligonucleotides were used for ssDNA binding and DNA synthesis analysis, respectively. Restriction sites for NdeI (CATATG) and XhoI (CTCGAG) are underlined.